May 2011 Issue of MMM
In Jack Arnold's 1957 cult sci-fi classic The Incredible Shrinking Man, businessman Robert Scott Carey is condemned to a life of shrinkage, for which there ...
Drug revenues barely kept pace last year, as other indicators like numbers of protected brands and reps have decreased, amid the overall trend of industry ...
Pharma is spending millions to prepare for the Sunshine Act. But with disclosure likely to drive negative press, drug firms should consider changing the way ...
Digital marketing of healthcare products is under assault. Pharma must up transparency and educate the public about the robust consumer privacy safeguards in place, writes ...
The MM&M Awards 2011 judging panel is in place and poised to descend on the Hotel Warwick in New York City on June 27 for ...
Ian Clark, Genentech's CEO and head of North American commercial operations, is this year's Healthcare Businesswomen's Association (HBA) Honorable Mentor
Understanding and measuring what motivates behavior is a central goal for many pharmaceutical market research projects.
Use of generic drugs has grown dramatically in the US, to the point where currently almost 75% of the drugs we use are generic.
The Patient Protection and Affordable Care Act turned one in March, and it was, for the drug industry, an ambivalent occasion.
Most US family medicine resident programs have limits on drug industry interaction with doctors, and a quarter shun doctor-company contacts altogether, said a survey by ...
A PhRMA-sponsored survey found that nearly eight in 10 US physicians see drug companies and their sales reps as useful sources of information on prescription ...
Featuring news about Physicians Interactive Holdings, Challenger Gray & Christmas, and GlaxoSmithKline
Med Ed Report
In a move aimed at better educating its members and reducing confusion between independent, CME-certified medical education and non-independent promotional events, the American College of ...
Interest in attending sponsored speaker programs in a traditional dinner program format is waning, says medical meetings producer Pri-Med.
The American Rhinologic Society (ARS) adopted a COI policy that permits transparent interactions between industry and ARS and its leadership.
Featuring news about Unbound Medicine, Publicis Touchpoint Solutions, Elsevier, Cleveland Clinic and Vindico Medical Education
For all the talk of e-detailing and digitizing the sales force, a plurality of international healthcare professionals would rather get info about new treatments from ...
Novartis is launching a global media review, reported Advertising Age.
Featuring news about Sermo, Janssen Global Services, Henry Schein Inc. and Wolters Kluwer Pharma Solutions
Teva's alliance with P&G should enable the drugmaker to get competitive rates on global media buys for its OTC products. Are there other opportunities for ...
Google is making its ads interactive with a "+1" button that will basically allow users to "like" ads and recommend them to their friends.
Social media "power users" who value interaction with healthcare companies want them regulated but around, according to a WEGO Health survey.
Featuring news about Capstrat-Public Policy Polling, American Medical Association and Good Health Media
BPH is one of those conditions that affects a large population and has physical symptomology that makes sufferers very uncomfortable.
Boehringer Ingelheim has recruited actress Jane Seymour to serve as the face of a continental European atrial fibrillation and stroke awareness campaign.
The UK's Prescription Medicines Code of Practice Authority, which arbitrates drug industry self-regulation there, issued "informal guidance" on digital communications, and while it's more than ...
Data indicate a noticeable step-up in the workload for market research pros based at pharmaceutical firms.
Ipsos Health hired nine researchers to support North American operations, including seven US- and two Canada-based staffers.
Havas Drive has launched a practice focused on developing digital products for persons with disabilities and those undergoing rehabilitative therapies.
InVentiv's GSW is going after the consumer health and wellness market with an offshoot, dubbed The Well @ GSW, aimed at OTC brands, consumer products ...
Featuring news about Cadient, GCI Health, Biocell Center and Allison & Partners
There's a generational element to the failure of the Obama administration's much-hyped agenda to increase transparency at government agencies like FDA, where reform has been ...
A federal judge has sentenced Forest Pharmaceuticals to pay a criminal fine of $150 million and forfeit $14 million in assets for its guilty plea ...
FDA says it plans to fine companies up to $10 million who lack "due diligence" in completing confirmatory trials for drugs granted accelerated approval.
The mobile advertising platform is a unique environment.
On Feb. 28, more than 30 countries across the world observed Rare Disease Day.
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.
A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.